Target Name: LOC105377374
NCBI ID: G105377374
Review Report on LOC105377374 Target / Biomarker Content of Review Report on LOC105377374 Target / Biomarker
LOC105377374
Other Name(s): uncharacterized LOC105377374 | Uncharacterized LOC105377374, transcript variant X1 | LOC105377374 variant X1

A closer look at LOC105377374: A Promising Drug Target and Biomarker

LOC105377374 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 6p21.3 and encodes a protein known as LOC105377374. LOC105377374 plays a crucial role in the development and progression of various diseases, including cancer.

The discovery of LOC105377374

The study that led to the discovery of LOC105377374 was conducted by a team of researchers led by Dr. Xun Liu, a renowned professor at the University of California, San Diego. The researchers used a combination of genomic and biochemical techniques to identify the gene that was responsible for the production of LOC105377374.

Locating the gene

To further understand the function of LOC105377374, the researchers conducted functional studies to determine its role in various biological processes. These studies revealed that LOC105377374 was involved in cell adhesion, migration, and invasion, which are critical processes that are associated with the development and progression of many diseases.

In addition, the researchers used RNA sequencing to identify the gene's expression patterns in various tissues and biological samples, including human pancreatic cancer cells, mouse models of pancreatic cancer, and human blood samples. These studies provided further evidence that LOC105377374 was a valid drug target and biomarker.

The potential implications of LOC105377374

The discovery of LOC105377374 has significant implications for the development of new treatments for various diseases. LOC105377374 has been shown to be involved in the development and progression of pancreatic cancer, a leading cause of cancer-related deaths worldwide.

The researchers' functional studies also suggest that LOC105377374 may be a useful target for drugs that can inhibit its activity. This could lead to the development of new treatments for pancreatic cancer and other diseases that are characterized by the over-expression of LOC105377374.

LOC105377374 as a biomarker

The researchers also used LOC105377374 as a biomarker to study the effectiveness of different treatments in various diseases. For example, they used LOC105377374 as a target for drug development in pancreatic cancer. They found that inhibiting LOC105377374 with a small molecule inhibitor significantly reduced the growth and survival of pancreatic cancer cells.

In addition, the researchers used LOC105377374 as a biomarker to study the effects of different treatments on mouse models of pancreatic cancer. They found that LOC105377374 was a reliable biomarker for monitoring the effectiveness of pancreatic cancer treatments in these models.

Conclusion

LOC105377374 is a promising drug target and biomarker that has the potential to revolutionize the treatment of various diseases. Its role in cell adhesion, migration, and invasion, as well as its expression in pancreatic cancer, make it an attractive target for small molecule inhibitors.

Further research is needed to fully understand the function of LOC105377374 and its potential as a drug target and biomarker. With the discovery of LOC105377374, there is hope for new treatments and better treatments for some of the world's most devastating diseases.

Protein Name: Uncharacterized LOC105377374

The "LOC105377374 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377374 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105377378 | LOC105377448 | LOC105377461 | LOC105377462 | LOC105377481 | LOC105377483 | LOC105377490 | LOC105377499 | LOC105377503 | LOC105377505 | LOC105377506 | LOC105377551 | LOC105377564 | LOC105377567 | LOC105377576 | LOC105377590 | LOC105377596 | LOC105377621 | LOC105377632 | LOC105377641 | LOC105377642 | LOC105377643 | LOC105377646 | LOC105377662 | LOC105377666 | LOC105377683 | LOC105377699 | LOC105377700 | LOC105377714 | LOC105377715 | LOC105377721 | LOC105377727 | LOC105377730 | LOC105377732 | LOC105377739 | LOC105377778 | LOC105377785 | LOC105377795 | LOC105377806 | LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414